awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38460859-ECB7D832-DAB9-4CD8-8B9A-5298DC6EE301
Q38460859-ECB7D832-DAB9-4CD8-8B9A-5298DC6EE301
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38460859-ECB7D832-DAB9-4CD8-8B9A-5298DC6EE301
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.
P1433
Q38460859-ECB7D832-DAB9-4CD8-8B9A-5298DC6EE301
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38460859-ECB7D832-DAB9-4CD8-8B9A-5298DC6EE301
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73cc73c8d6b25d5571a582bcf16b8e245bc8016a
P1433
Cancer Chemotherapy and Pharmacology